HOUSTON HEALTHCARE SPECIALTY HOSP. — History
CCN 452046 | 3-year financial timeline | COVID resilience: 17/100
🛡️ Public data only — no PHI permitted on this instance.
$21M
Latest Revenue (FY2022)
-11.8%
Revenue CAGR (3yr)
-2.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $27M | $32M | $21M | -33.6% | -11.8% |
| Operating Expenses | $26M | $29M | $22M | -24.9% | -9.0% |
| Operating Margin | 3.2% | 8.9% | -2.9% | -132.5% | +0.0% |
| Net Income | $1M | $3M | $-1M | -121.6% | +0.0% |
| Licensed Beds | 44 | 39 | 39 | +0.0% | -5.9% |
| Total Patient Days | 15,143 | 12,514 | 7,579 | -39.4% | -29.3% |
| Medicare Day % | 27% | 30% | 50% | +67.2% | +35.6% |
| Medicaid Day % | nan% | 0% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 17/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -22.2% ($27M → $21M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-11.8%
This Hospital
+7.6%
State Avg
Latest Margin
-2.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $18M | -6.0% |
| FY2024 (proj) | $15M | -9.0% |
| FY2025 (proj) | $12M | -12.1% |